Limin Xiong

Title: Limin Xiong: Innovator in Biotech

Introduction

Limin Xiong is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins for adalimumab. With a total of 2 patents, his work has implications for both clinical settings and research.

Latest Patents

Limin Xiong's latest patents focus on compositions and methods comprising binding proteins for adalimumab. Adalimumab is a monoclonal antibody that targets the cytokine TNF-α, which is crucial in treating TNF-α mediated inflammatory diseases. His inventions include antibodies directed toward adalimumab, which can be utilized to neutralize the effects of this antibody in various applications. These binding proteins, including their fragments, are valuable for both clinical and research purposes.

Career Highlights

Limin Xiong is currently employed at AbbVie Biotechnology Ltd., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing therapeutic options for inflammatory diseases.

Collaborations

Limin collaborates with Zehra Kaymakcalan, contributing to the innovative environment at AbbVie Biotechnology Ltd. Their partnership enhances the research and development efforts within the company.

Conclusion

Limin Xiong's contributions to biotechnology, particularly through his patents related to adalimumab, highlight his role as an influential inventor in the field. His work not only advances scientific understanding but also has practical applications in treating inflammatory diseases.